What the label lists and what reports show
Betiatide side effects
Betiatide's FDA label lists its adverse reactions in its own words. FAERS holds 109 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is dyspnoea (11 reports).
- Generic listed
Check it at the source: the betiatide FDA label on DailyMed (effective January 6, 2026); the FDA FAERS public dashboard.
What does the label list?
From the label: adverse reactionsThe following adverse reactions have been reported: nausea, vomiting, wheezing, dyspnea, itching, rash, tachycardia, hypertension, shaking chills, fever, and seizure.
Source: FDA drug label, Curium US LLC, effective January 6, 2026 (SPL set 0571c18b-1d5e-47bd-bddf-54d74ce1b442), via openFDA; the full label on DailyMed
What do FAERS reports show?
109 reports list betiatide among the medicines taken, each a report of something that happened, not proof the medicine caused it; 5 are coded as a death and 12 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 23 reactions below, 6 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.
The 25 most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms
What next?
- Betiatide: the full record
- label, generics, price, shortages, recalls
- Report a side effect to the FDA
- MedWatch
- Side effects hub
- the most reported medicines and reactions